ProfileGDS5678 / 1455934_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 9% 10% 10% 10% 10% 10% 10% 10% 10% 10% 10% 10% 10% 10% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.251829
GSM967853U87-EV human glioblastoma xenograft - Control 22.2466310
GSM967854U87-EV human glioblastoma xenograft - Control 32.2433110
GSM967855U87-EV human glioblastoma xenograft - Control 42.195410
GSM967856U87-EV human glioblastoma xenograft - Control 52.1920410
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3046210
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.2662910
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2262410
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2138310
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2341610
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2348110
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.235910
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2454910
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2394510